FGL

🔹 What is FGL?

Class: 15-amino-acid peptide (sequence Glu-Val-Tyr-Val-Val-Ala-Glu-Asn-Gln-Gln-Gly-Lys-Ser-Lys-Ala, MW 3432.62 g/mol; short for Fibroblast Growth Loop), classified as a neurotrophic peptide. More precisely, FGL is a variant of the natural neural cell adhesion molecule (NCAM) that was engineered specifically as a fibroblast growth factor receptor agonist — it activates FGFR1 signaling directly, rather than acting as a hormone or generic receptor agonist in the way most other compounds on this site do. Mechanism:

• Supports neuron growth, survival, and synapse formation — the basic wiring and rewiring that underlies learning and memory. It’s considered essential for both early synaptogenesis and later synaptic maturation, and it influences the strength of excitatory synapses in an activity-dependent manner.
• Early mechanistic work (cell culture and rodent studies) points to several possible pathways: protection against neurotoxicity, anti-neuroinflammatory activity, and support for cognitive recovery after stroke or traumatic brain injury. No single mechanism stands out as clearly dominant over the others in the available data.
• Notably experimental: there’s no meaningful human trial data behind FGL, which puts it further out on the speculative end compared to most other cognitive peptides covered here.

Primary focus:

• Learning and memory support, framed as a nootropic/cognitive-enhancement peptide.
• Explored (in early research, not human trials) for neuroprotection and post-injury cognitive recovery.

---

🔹 Injectable / Subcutaneous Dosage (only reported route) Range:

• 1–2 mg subcutaneously, injected into the abdomen, once daily.

Frequency:

• A “5 days on, 2 days off” cycle is the most commonly cited protocol, dosed roughly 4–6 times a week within that pattern.

Rationale: This dosing comes from Dr. William Seeds’ published peptide protocols rather than clinical trial data — treat it as a starting reference point, not an established standard. Younger users (under 30, and generally into the early 30s) are advised to stay toward the lower 1 mg dose and run it as a 6-week trial before reassessing response, rather than escalating early.

---

🔹 Cycle Length Common cycle length: Ongoing use with the built-in 5-days-on/2-days-off weekly rhythm, rather than multi-week on/off blocks like GH secretagogues. Note: Given the lack of human data, there’s no well-established guidance on optimal total duration — this is one to approach cautiously and reassess regularly.

---

🔹 Optimal Dosing Window

• No strong time-of-day rationale has been established — daily subcutaneous dosing into the abdomen is the extent of what’s documented.

---

✅ Educational Integration Example (subcutaneous)

• Example protocol: 1 mg subcutaneously into the abdomen daily, 5 days on / 2 days off, starting at the lower end of the range and self-assessing cognitive effects over several weeks.
• Community reports are genuinely mixed — some describe noticeable improvements in learning and mood, others report no meaningful effect even at higher doses. This is one where individual response varies more than most.

---

🔹 Stacking Strategy (Educational / Complementary) Since FGL’s role is neurotrophic and experimental, complementary stacking tends to lean toward other cognitive-support compounds with better-established track records: 🔸 Cognitive & Neuroprotective Support:

• Semax, Selank: More established cognitive peptides that can round out a stack if FGL’s specific neurotrophic mechanism doesn’t produce noticeable effects on its own.
• Dihexa, Cerebrolysin: Other neuro-focused compounds already covered on this site with different but complementary mechanisms.

Rationale: Given how experimental and individually variable FGL’s effects appear to be, stacking logic here leans toward pairing it with better-studied cognitive peptides rather than relying on it alone.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.